台湾肺炎治疗建议与指南
该指南由2017年GREAT工作组制定,由台湾感染症医学会(IDST)与台湾胸腔暨重症加护医学会(TSPCCM)等联合召开共识会议,最终由IDST和TSPCCM共同认可。与2007版相比,主要差异包括:在适用情况下采用GRADE方法评估现有证据,因台湾医疗体系独特而将医疗照护相关肺炎单独列为类别,并纳入儿童肺炎治疗建议。指南涵盖社区获得性肺炎、医院获得性肺炎、呼吸机相关性肺炎、医疗照护相关肺炎(成人)及儿童肺炎的流行病学与抗菌治疗建议。
要点
- 指南由IDST与TSPCCM联合认可,涵盖社区获得性、医院获得性、呼吸机相关性、医疗照护相关肺炎(成人)及儿童肺炎的抗菌治疗建议。
- 与2007版相比,本指南在适用情况下采用GRADE方法评估证据。
- 因台湾医疗体系独特,本指南将医疗照护相关肺炎单独列为类别并给出治疗建议。
- 本指南新增儿童肺炎治疗建议。
适用人群与场景
- 成人社区获得性肺炎、医院获得性肺炎、呼吸机相关性肺炎、医疗照护相关肺炎患者及儿童肺炎患者。
研究设计与关键结果
- 指南由2017年GREAT工作组制定,在IDST支持下成立,由IDST、TSPCCM、德林郑医学基金会、谢维铨教授感染症研究教育基金会及CY Lee儿科感染症疫苗研究基金会联合召开共识会议,最终由IDST和TSPCCM认可。
- 与2007版的主要差异包括:在适用情况下采用GRADE方法评估现有证据、因台湾医疗体系独特而将医疗照护相关肺炎单独列为类别、纳入儿童肺炎治疗建议。
证据类型、等级与局限
- 证据类型:指南(由IDST与TSPCCM联合认可)。
- 在适用情况下采用GRADE方法评估现有证据。
- 局限:原文未报告局限性
指南或共识出处
- Recommendations and guidelines for the treatment of pneumonia in Taiwan(台湾肺炎治疗建议与指南),由台湾感染症医学会(IDST)与台湾胸腔暨重症加护医学会(TSPCCM)联合认可。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Pneumonia is a leading cause of death worldwide, ranking third both globally and in Taiwan. This guideline was prepared by the 2017 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, formed under the auspices of the Infectious Diseases Society of Taiwan (IDST). A consensus meeting was held jointly by the IDST, Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), the Medical Foundation in Memory of Dr. Deh-Lin Cheng, the Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education and CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. The final guideline was endorsed by the IDST and TSPCCM. The major differences between this guideline and the 2007 version include the following: the use of GRADE methodology for the evaluation of available evidence whenever applicable, the specific inclusion of healthcare-associated pneumonia as a category due to the unique medical system in Taiwan and inclusion of recommendations for treatment of pediatric pneumonia. This guideline includes the epidemiology and recommendations of antimicrobial treatment of community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, healthcare-associated pneumonia in adults and pediatric pneumonia.
参考来源
- Chou CC, Shen CF, Chen SJ, et al. Recommendations and guidelines for the treatment of pneumonia in Taiwan. J Microbiol Immunol Infect. 2018. PMID: 30612923. doi:10.1016/j.jmii.2018.11.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。